SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-192794
Filing Date
2017-06-02
Accepted
2017-06-02 15:10:03
Documents
2
Period of Report
2017-06-02
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d398550d8k.htm 8-K 17714
2 EX-99.1 d398550dex991.htm EX-99.1 13264
  Complete submission text file 0001193125-17-192794.txt   32160
Mailing Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301
Business Address 3122 STERLING CIRCLE, SUITE 200 BOULDER CO 80301 720-945-7700
Nivalis Therapeutics, Inc. (Filer) CIK: 0001626199 (see all company filings)

IRS No.: 208969493 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37449 | Film No.: 17887568
SIC: 2834 Pharmaceutical Preparations